UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to address longstanding complaints that expensive prescriptions are losing ...

We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are ...

In the latest trading session, UnitedHealth Group (UNH) closed at $516.85, marking a +1.09% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.08% for the day.

The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...

A UnitedHealth Group Inc. subsidiary won court approval of a $20.25 million settlement with the US Labor Department over ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...

The global clinical informatics market, valued at US$ 198.33 Billion in 2023, is forecasted to grow at a robust CAGR of 16.0% ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

The Justice Department’s years-long court battle to force UnitedHealth Group to return billions of dollars in alleged Medicare Advantage overpayments hit a major setback Monday when a special master ...